(Total Views: 206)
Posted On: 03/19/2021 10:18:31 AM
Post# of 145123
MRKR Announces Price Target of $6
Cantor Fitzgerald Initiates Coverage On Marker Therapeutics with Overweight Rating, Announces Price Target of $6
8:26 am ET March 19, 2021 (Benzinga) Print
Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Marker Therapeutics (NASDAQ:MRKR) with a Overweight rating and announces Price Target of $6.
Latest Ratings for MRKR DateFirmActionFromTo
Mar 2021Cantor FitzgeraldInitiates Coverage OnOverweight Mar 2021Cantor FitzgeraldInitiates Coverage OnOverweight May 2020Piper SandlerDowngradesOverweightNeutral
View More Analyst Ratings for MRKR
View the Latest Analyst Ratings
Cantor Fitzgerald Initiates Coverage On Marker Therapeutics with Overweight Rating, Announces Price Target of $6
8:26 am ET March 19, 2021 (Benzinga) Print
Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Marker Therapeutics (NASDAQ:MRKR) with a Overweight rating and announces Price Target of $6.
Latest Ratings for MRKR DateFirmActionFromTo
Mar 2021Cantor FitzgeraldInitiates Coverage OnOverweight Mar 2021Cantor FitzgeraldInitiates Coverage OnOverweight May 2020Piper SandlerDowngradesOverweightNeutral
View More Analyst Ratings for MRKR
View the Latest Analyst Ratings
(0)
(0)
